Parker, Jayson Lee, et al. “Clinical Trial Risk in Non-Hodgkin’s Lymphoma: Endpoint and Target Selection”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 14, no. 2, June 2011, pp. 227-35, doi:10.18433/J39P45.